We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Development of an UPLC–MS/MS assay to determine psoralidin in rat plasma and its application in a pharmacokinetic study after intragastric administration.
- Authors
Feng, Feng; Jiang, Xiunan; Qiu, Jieying; Wu, Hongyu; Cai, Xiaojun; Xiang, Zheng
- Abstract
Psoralidin has a variety of pharmacological activities, such as anti-tumor, anti-depressant, and anti-inflammatory activities. This study aims at developing a rapid ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) method to determine psoralidin in rat plasma and studying the pharmacokinetic characteristic of psoralidin after intragastric administration of 20 and 40 mg/kg. Alpinetin was used as an internal standard (IS), and the plasma samples were precipitated with acetonitrile. The calibration curves were linear over the range of 0.2–250 ng/mL (R2 = 0.993). The pharmacokinetic parameters were calculated by DAS 3.0. Half-life (t1/2) was 7.2 ± 0.97 h and 7.1 ± 0.27 h for different dosages, respectively. Tmax was 4.2 ± 1.1 h and 4.0 ± 1.1 h for different dosages, respectively. Apparent volume of distribution (Vd) for different dosages was 630.1 ± 168.8 and 600.1 ± 138.8 L/kg, respectively. Clearance (CL) was 105.6 ± 29.2 and 100.6 ± 22.2 L/h/kg for different dosages, indicating that psoralidin was mainly distributed in rat tissues. The pharmacokinetic study provided important information for further clinical application in the treatment of cancer and osteoporosis.
- Subjects
TANDEM mass spectrometry; GASTRIC mucosa; LIQUID chromatography-mass spectrometry; PHARMACOKINETICS; RATS
- Publication
Acta Chromatographica, 2020, Vol 32, Issue 4, p215
- ISSN
1233-2356
- Publication type
Article
- DOI
10.1556/1326.2019.00679